July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Folate decorated polymeric nanoparticles for enhanced lutein uptake for treatment of age-related macular degeneration
Author Affiliations & Notes
  • Jwala Renukuntla
    UTEP School of Pharmacy, El Paso, Texas, United States
  • Pradeep Kumar Bolla
    UTEP School of Pharmacy, El Paso, Texas, United States
  • Rahul Kalhapure
    UTEP School of Pharmacy, El Paso, Texas, United States
  • Abhishek Arnipalli
    UTEP School of Pharmacy, El Paso, Texas, United States
  • Julian Franco
    UTEP School of Pharmacy, El Paso, Texas, United States
  • Carlos Meraz
    UTEP School of Pharmacy, El Paso, Texas, United States
  • Footnotes
    Commercial Relationships   Jwala Renukuntla, None; Pradeep Kumar Bolla, None; Rahul Kalhapure, None; Abhishek Arnipalli, None; Julian Franco, None; Carlos Meraz, None
  • Footnotes
    Support  Start up
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2998. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jwala Renukuntla, Pradeep Kumar Bolla, Rahul Kalhapure, Abhishek Arnipalli, Julian Franco, Carlos Meraz; Folate decorated polymeric nanoparticles for enhanced lutein uptake for treatment of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2998.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age-related macular degeneration (AMD) is one of the major causes of blindness in elderly people. AMD is a neurodegenerative disease affecting the posterior segment of the eye. Lutein, a carotenoid with anti-oxidant properties has shown neuroprotective properties in the retina. Drug delivery to the posterior segment of the eye is challenging due to blood retinal barrier. Retinal pigment epithelium (RPE) expresses folate receptors which selectively uptake folic acid by active transport. Therefore, the purpose of this study is to enhance uptake of lutein by formulating lutein loaded PLGA-PEG-FOL nanoparticles.

Methods : Lutein loaded PLGA and PLGA-PEG-FOL nanoparticles were prepared using double emulsion solvent evaporation method. Size, zeta potential and polydispersity index were determined using Zetasizer Nano ZS (Malvern Instruments, U.K.). Lutein encapsulation efficiency (%EE) and drug loading (%DL) capacity in freeze dried nanoparticles was measured using HPLC. Differential scanning calorimetry (DSC) was used to confirm the encapsulation of lutein. Scanning electron microscopy revealed that nanoparticles were spherical in shape. Selective uptake of lutein in ARPE-19 cells is underway in our laboratory.

Results : Mean diameter (±SD) of lutein loaded nanoparticles formulated using PLGA and PLGA-PEG-FOL was 132.6 ± 1.041 nm and 188.0 ± 4.058 nm, respectively. %EE and %DL of lutein-PLGA nanoparticles was 48.82 ± 15.50 and 9.76 ± 3.10%, respectively, whereas, it was 72.87 ± 7.22% and 14.57 ± 1.44% for PLGA-PEG-FOL nanoparticles. DSC results confirmed that lutein was encapsulated into the nanoparticles.

Conclusions : We have successfully formulated lutein encapsulated PLGA and PLGA-PEG-FOL nanoparticles with particle size <200 nm. Both the formulations showed good encapsulation and drug loading. Other characterizations and evaluations such as in-vitro release profile and cellular uptake are underway.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×